Trio Pharmaceuticals
Latest round
- Series A
Last raised
- Dec 2024
Total raised
- $4.6M
Investors
- 5
About Trio Pharmaceuticals
Based in California, US, and founded in 2018 by its CEO Reiner Laus, and COO Shiva Bhowmik, Trio Pharmaceuticals Inc. operates as a cancer immunotherapeutics company that specializes in developing dual-action drugs to generate immunogenic tumors. In December 2024, Trio Pharmaceuticals Inc. Trio Pharmaceuticals Inc. offers a platform of dual-action tumor immunity-enhancing drugs targets specific antigens on cancer cells and immunosuppressor cells, selectively stopping tumor growth and immunosuppression in the tumor without targeting the immune checkpoint pathways.
Who invested in Trio Pharmaceuticals
5 investors across 2 rounds
See all investors in Trio Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Trio Pharmaceuticals
Who invested in Trio Pharmaceuticals?
Trio Pharmaceuticals has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Trio Pharmaceuticals raised?
Trio Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Trio Pharmaceuticals last raise money?
Trio Pharmaceuticals's most recent round on record is a Series A, in Dec 2024.
What does Trio Pharmaceuticals do?
Based in California, US, and founded in 2018 by its CEO Reiner Laus, and COO Shiva Bhowmik, Trio Pharmaceuticals Inc.
Where is Trio Pharmaceuticals headquartered?
Trio Pharmaceuticals is headquartered in San Francisco, US.
Which VCs invest in companies like Trio Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Trio Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Trio Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.